Medication-Wide Association Study Using Electronic Health Record Data of Prescription Medication Exposure and Multifetal Pregnancies: Retrospective Study
BackgroundMedication-wide association studies (MWAS) have been applied to assess the risk of individual prescription use and a wide range of health outcomes, including cancer, acute myocardial infarction, acute liver failure, acute renal failure, and upper gastrointestinal ul...
Main Authors: | Lena Davidson, Silvia P Canelón, Mary Regina Boland |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2022-06-01
|
Series: | JMIR Medical Informatics |
Online Access: | https://medinform.jmir.org/2022/6/e32229 |
Similar Items
-
A medication-wide association study (MWAS) on repurposed drugs for COVID-19 with Pre-pandemic prescription medication exposure and pregnancy outcomes
by: Lena Davidson, et al.
Published: (2022-11-01) -
Generalized tuberculosis and multifetal pregnancy
by: P. O. Sotskiy, et al.
Published: (2020-03-01) -
Abortion and multifetal pregnancy reduction: An ethical comparison
by: Silje Langseth Dahl, et al.
Published: (2021-06-01) -
Multifetal pregnancy reduction outcomes from triplets to singletons and twins
by: Zeynep Gedik Özköse, et al.
Published: (2022-04-01) -
Short Interpregnancy Interval Following a Multifetal Pregnancy: Maternal and Neonatal Outcomes
by: Ari Weiss, et al.
Published: (2023-03-01)